Literature DB >> 9225048

Sequence heterogeneity of heron hepatitis B virus genomes determined by full-length DNA amplification and direct sequencing reveals novel and unique features.

H J Netter1, S Chassot, S F Chang, L Cova, H Will.   

Abstract

So far, only a single heron hepatitis B virus genome (HHBV-4) has been cloned and sequenced. Therefore, neither the significance of its sequence divergence from other avian hepadnaviruses nor the sequence variability of HHBV genomes in general are known. Here we have analysed the sequence heterogeneity of HHBV genome populations in several sera from naturally infected herons. A highly sensitive PCR method for full-length HHBV genome amplification was established which allowed direct sequencing of entire HHBV populations without prior cloning. Sequences of HHBV genomes from four sera were thus obtained which differed from those of HHBV-4 by up to 7%. Some of the divergent nucleotides and the corresponding amino acids of the predicted viral proteins were conserved in all four new HHBV isolates and varied only in HHBV-4. This indicates that the HHBV-4 genome is not in all aspects representative of this class of viruses. Interestingly, a highly conserved ORF upstream of the C-gene present in a position analogous to that of the mammalian hepadnavirus X-gene became apparent in all HHBV genomes. In contrast to the duck hepadnaviruses, the small (sAg-S) instead of the largest (sAg-L) envelope protein of all HHBVs has a myristylation site. These data confirm the significant sequence divergence of HHBV from other avian hepadnaviruses. Moreover, they show that HHBV has low sequence variability and indicate two new and unique features not evident in other avihepadnaviruses: an additional, highly conserved gene and potential myristylation of the sAg-S instead of the sAg-L envelope protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225048     DOI: 10.1099/0022-1317-78-7-1707

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Frequency of spontaneous mutations in an avian hepadnavirus infection.

Authors:  I Pult; N Abbott; Y Y Zhang; J Summers
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Entry of duck hepatitis B virus into primary duck liver and kidney cells after discovery of a fusogenic region within the large surface protein.

Authors:  Claudia Maenz; Shau-Feng Chang; Alicja Iwanski; Michael Bruns
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

4.  Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.

Authors:  Marc F Le Mire; Darren S Miller; Wendy K Foster; Christopher J Burrell; Allison R Jilbert
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame.

Authors:  S F Chang; H J Netter; E Hildt; R Schuster; S Schaefer; Y C Hsu; A Rang; H Will
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity.

Authors:  Haitao Guo; William S Mason; Carol E Aldrich; Jeffry R Saputelli; Darren S Miller; Allison R Jilbert; John E Newbold
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Molecular characterization of duck hepatitis B virus isolates from South African ducks.

Authors:  Nomathibane P Mangisa; Heidi E Smuts; Anna Kramvis; C Wendy Linley; Michelle Skelton; Timothy J Tucker; Pauline De La M Hall; Del Kahn; Allison R Jilbert; Michael C Kew
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

8.  New hepatitis B virus of cranes that has an unexpected broad host range.

Authors:  Alexej Prassolov; Heinz Hohenberg; Tatyana Kalinina; Carola Schneider; Lucyna Cova; Oliver Krone; Kai Frölich; Hans Will; Hüseyin Sirma
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.